Copy-number variations in adult patients with chronic immune thrombocytopenia

References

• George JN, el-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1994 Nov;331(18):1207–1211.
   PubMed Web of Science ®Google Scholar
• Schoonen WM, Kucera G, Coalson J, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009 Apr;145(2):235–244.
   PubMed Web of Science ®Google Scholar
• Iraqi M, Perdomo J, Yan F, et al. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica. 2015 May;100(5):623–632.
   PubMed Web of Science ®Google Scholar
• Liu XG, Liu S, Feng Q, et al. Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP. Blood. 2016 Aug;128(6):852–861.
   PubMed Web of Science ®Google Scholar
• Audia S, Santegoets K, Laarhoven AG, et al. Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia. Clin Exp Immunol. 2017 May;188(2):275–282.
   PubMed Web of Science ®Google Scholar
• Li J, van der Wal DE, Zhu G, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun. 2015 Jul;17(6):7737.
   Google Scholar
• Karpatkin S, Fotino M, Winchester R. Hereditary autoimmune thrombocytopenic purpura: an immunologic and genetic study. Ann Intern Med. 1981 Jun;94(6):781–782.
   PubMed Web of Science ®Google Scholar
• Laster AJ, Conley CL, Kickler TS, et al. Chronic immune thrombocytopenic purpura in monozygotic twins: genetic factors predisposing to ITP. N Engl J Med. 1982 Dec;307(24):1495–1498.
   PubMed Web of Science ®Google Scholar
• Imbach P, Kühne T, Signer E. Historical aspects and present knowledge of idiopathic thrombocytopenic purpura. Br J Haematol. 2002 Dec;119(4):894–900.
   PubMed Web of Science ®Google Scholar
• Breunis WB, van Mirre E, Bruin M, et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood. 2008 Feb;111(3):1029–1038.
   PubMed Web of Science ®Google Scholar
• van Dongen JJM, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003 Dec;17(12):2257–2317.
   PubMed Web of Science ®Google Scholar
• Rischewski JR, Imbach P, Paulussen M, et al. Idiopathic thrombocytopenic purpura (ITP): is there a genetic predisposition? Pediatr Blood Cancer. 2006 Aug;47(S5):678–680.
   PubMedGoogle Scholar
• Shimojima K, Yamamoto T. Characteristics of rare and private deletions identified in phenotypically normal individuals. Hum Genome Var. 2017 Sep;14(4):17037.
   Google Scholar
• McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet. 2007 Jul;39(7 Suppl):S37–42.
   PubMedGoogle Scholar
• Schaschl H, Aitman TJ, Vyse TJ. Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol. 2009 Apr;156(1):12–16.
   PubMed Web of Science ®Google Scholar
• Fitzer-Attas CJ, Lowry M, Crowley MT, et al. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J Exp Med. 2000 Feb;191(4):669–682.
   PubMed Web of Science ®Google Scholar
• Majeed M, Caveggion E, Lowell CA, et al. Role of Src kinases and Syk in Fcgamma receptor-mediated phagocytosis and phagosome-lysosome fusion. J Leukoc Biol. 2001 Nov;70(5):801–811.
   PubMed Web of Science ®Google Scholar
• Tabach Y, Kogan-Sakin I, Bugamin Y, et al. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLoS One. 2011 Jan;6(1):e14632.
   PubMed Web of Science ®Google Scholar
• Peng HL, Zhang Y, Sun NN, et al. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia. J Thromb Haemost. 2017 Nov;15(11):2259–2269.
   PubMed Web of Science ®Google Scholar
• Salzer U, Chapel HM, Webster ADB, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005 Aug;37(8):820–828.
   PubMed Web of Science ®Google Scholar
• Siddiqa A, Sims-Mourtada JC, Guzman-Rojas L, et al. Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA. Nature. 2001 Mar 15;410(6826):383–387.
   PubMed Web of Science ®Google Scholar
• Huber AK, Finkelman FD, Li CW, et al. Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J Immunol. 2012 Sep 15;189(6):3043–3053.
   PubMed Web of Science ®Google Scholar
• Cui D, Lv Y, Yuan X, et al. Increased expressions of OX40 and OX40 ligand in patients with primary immune thrombocytopenia. J Immunol Res. 2019 Mar 3;2019:6804806.
   PubMed Web of Science ®Google Scholar
• Fiehn C. Familial chilblain lupus - what can we learn from type I interferonopathies? Curr Rheumatol Rep. 2017 Aug 26;19(10):61.
   PubMed Web of Science ®Google Scholar
• Ozsahin H, Arredondo-Vega FX, Santisteban I, et al. Adenosine deaminase deficiency in adults. Blood. 1997 Apr 15;89(8):2849–2855.
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015 May;14(4):27066.
   Web of Science ®Google Scholar
• Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014 Mar;14(3):195–208.
   PubMed Web of Science ®Google Scholar
• Pleines I, Dütting S, Cherpokova D, et al. Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42. Blood. 2013 Oct;122(18):3178–3187.
   PubMed Web of Science ®Google Scholar
• Laurie CC, Laurie CA, Rice K, et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet. 2012 May;44(6):642–650.
   PubMed Web of Science ®Google Scholar
• Bakchoul T, Sachs UJ. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms. Hamostaseologie. 2016 Aug;36(3):187–194.
   PubMed Web of Science ®Google Scholar
• Ware RE, Howard TA. Elevated numbers of gamma-delta (gamma delta+) T lymphocytes in children with immune thrombocytopenic purpura. J Clin Immunol. 1994 Jul;14(4):237–247.
   PubMed Web of Science ®Google Scholar
• Kim J, Park CJ, Chi HS, et al. Idiopathic thrombocytopenic purpura: better therapeutic responses of patients with B- or T-cell clonality than patients without clonality. Int J Hematol. 2003 Dec;78(5):461–466.
   PubMed Web of Science ®Google Scholar